video
2dn
video2dn
Найти
Сохранить видео с ютуба
Категории
Музыка
Кино и Анимация
Автомобили
Животные
Спорт
Путешествия
Игры
Люди и Блоги
Юмор
Развлечения
Новости и Политика
Howto и Стиль
Diy своими руками
Образование
Наука и Технологии
Некоммерческие Организации
О сайте
Видео ютуба по тегу Azurrx Ceo
James Sapirstein, President and CEO at AzurRx BioPharma
Thjis Spoor from AzurRx Biopharma on CEO Money
AzurRx CEO James Sapirstein discusses the Company's recently licensed niclosamide asset
AzurRx Cultivates Therapeutic Proteins for GI Disorder Treatment
James Sapirstein, CEO of AzurRx BioPharma, Inc. talks about AZRX’s products and therapies.
AzurRx's (AZRX) CEO Thijs Spoor - Investors can expect upcoming news about Phase 2 trial results
James Sapirstein, CEO of AzurRx BioPharma, Inc. talks about their biopharmaceutical products.
AzurRX (AZRX) recap of 2016 company highlights
AzurRx Biopharma Ceo Discusses Covid Variants, What He Is Excited About, Company Strategy! $AZRX
AzurRX Biopharma (NASDAQ: AZRX): Next Generation Targeted GI Therapies
Investor Brand Network (IBN) podcast host Stuart Smith interviews AzurRx CEO, James Sapirstein
Thijs Spoor of AzurRx Provides a Company Overview
Best Biopharma Industry Stocks To Invest In Today - AzurRx Biopharma CEO Interview
AzurRx BioPharma, Inc. (NASDAQ: AZRX)
AzurRx BioPharma (NASDAQ: AZRX) | James Sapirstein, President & CEO | Innovators with Jane King
AzurRx BioPharma, Inc.’s (NASDAQ:AZRX) interview with James Sapirstein, Chairman & CEO
AzurRx BioPharma, Inc. (NASDAQ: AZRX) Webcast | SNN Network
AzurRx BioPharma Describes Phase 2 Clinical Trial for Cystic Fibrosis and Value Catalysts
Stock2Me Podcast featuring AzurRx Biopharma Inc. President & CEO James Sapirstein
AzurRx: the latest stock pick for the 16.5% per year high growth Richmond Club Index
Следующая страница»